ENHANCING HEPATITIS C VIRUS TESTING, LINKAGE TO CARE AND DIRECT-ACTING ANTIVIRAL TREATMENT FOR PEOPLE WHO INJECT DRUGS

被引:0
|
作者
Grebely, Jason
机构
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
引用
收藏
页码:16 / 16
页数:1
相关论文
共 50 条
  • [21] Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
    Grebely, Jason
    Bruneau, Julie
    Lazarus, Jeffrey V.
    Dalgard, Olav
    Bruggmann, Philip
    Treloar, Carla
    Hickman, Matthew
    Hellard, Margaret
    Roberts, Teri
    Crooks, Levinia
    Midgard, Havard
    Larney, Sarah
    Degenhardt, Louisa
    Alho, Hannu
    Byrne, Jude
    Dillon, John F.
    Feld, Jordan J.
    Foster, Graham
    Goldberg, David
    Lloyd, Andrew R.
    Reimer, Jens
    Robaeys, Geert
    Torrens, Marta
    Wright, Nat
    Maremmani, Icro
    Norton, Brianna L.
    Litwin, Alain H.
    Dore, Gregory J.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 47 : 51 - 60
  • [22] PATIENT-CENTEREDNESS IN HEPATITIS C TREATMENT INTERVENTIONS AMONG PEOPLE WHO INJECT DRUGS IN THE DIRECT-ACTING ANTIVIRAL ERA: A SCOPING REVIEW
    Abdelwadoud, Moaz
    Mattingly, T. Joseph, II
    Segui, Hemanuel Arroyo
    Gorman, Emily F.
    Perfetto, Eleanor M.
    HEPATOLOGY, 2020, 72 : 431A - 432A
  • [23] Direct-acting antiviral agents for HCV infection affecting people who inject drugs
    Grebely, Jason
    Hajarizadeh, Behzad
    Dore, Gregory J.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (11) : 641 - 651
  • [24] Direct-acting antiviral agents for HCV infection affecting people who inject drugs
    Jason Grebely
    Behzad Hajarizadeh
    Gregory J. Dore
    Nature Reviews Gastroenterology & Hepatology, 2017, 14 : 641 - 651
  • [25] How can general practitioners support people who inject drugs to engage with direct-acting antiviral treatment for hepatitis C? A qualitative study
    Heard, Emma
    Smirnov, Andrew
    Massi, Luciana
    Selvey, Linda A.
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2021, 50 (10) : 716 - 721
  • [26] Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs
    Scott, N.
    Iser, D.
    Thompson, A.
    Doyle, J.
    Hellard, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 90 - 90
  • [27] Changes in hepatitis C virus prevalence and incidence among people who inject drugs in the direct acting antiviral era
    Gahrton, Caroline
    Naver, Georg
    Warnqvist, Anna
    Dalgard, Olav
    Aleman, Soo
    Kaberg, Martin
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2024, 128
  • [28] "It's not Simple and It's Not Straight Forward": Challenges and Opportunities in Scaling up Access of Direct-Acting Antiviral Hepatitis C Virus Treatment to People Who Inject Drugs
    Goodyear, Trevor
    Ti, Lianping
    Small, Will
    Knight, Rod
    INTERNATIONAL JOURNAL OF QUALITATIVE METHODS, 2020, 19
  • [29] Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study
    Draper, Bridget Louise
    Pedrana, Alisa
    Howell, Jessica
    Yee, Win Lei
    Htay, Hla
    Aung, Khin Sanda
    Shilton, Sonjelle
    Kyi, Khin Pyone
    Naing, Win
    Hellard, Margaret
    JMIR RESEARCH PROTOCOLS, 2020, 9 (07):
  • [30] Treatment Failure and Resistance with Direct-Acting Antiviral Drugs Against Hepatitis C Virus
    Pawlotsky, Jean-Michel
    HEPATOLOGY, 2011, 53 (05) : 1742 - 1751